Infectious Diseases : A Geographic Guide.

Intro -- Title Page -- Copyright Page -- Contents -- List of contributors -- Foreword to the first edition -- Foreword to the second edition -- Preface -- Envoi -- Chapter 1 Historical overview of global infectious diseases and geopolitics -- Introduction -- The Near East and North Africa -- Europe -- The Americas -- Australasia -- Sub-Saharan Africa -- South Asia -- East Asia -- Conclusion -- Acknowledgment -- References -- Chapter 2 Nontraditional infectious diseases surveillance systems -- Introduction: informal internet sources for the surveillance of emerging infectious diseases -- A convergence of trends -- ProMED-mail today -- HealthMap -- Infectious disease surveillance in travelers and migrants -- GeoSentinel surveillance network -- One health -- Regional ProMED networks -- Effectiveness of informal‐source surveillance -- Mobile technologies -- Mobile applications for infectious diseases -- Conclusion -- References -- Chapter 3 Air travel − which infectious disease control measures are worthwhile? -- Introduction -- Measles -- Rubella -- Enteric diseases -- Travel-specific behaviors for preventing disease -- Universal disease control behaviors -- Role of healthcare providers and healthcare workers -- Health facility infection control measures -- Airline responsibilities -- Large-scale infectious disease control measures -- Evaluation of the effectiveness of infectious disease control measures -- Recommendations -- References -- Chapter 4 Infectious illnesses on cruise and cargo ships -- Introduction and background -- Influenza -- Acute gastroenteritis -- Vaccine-preventable diseases -- Varicella (chickenpox) -- Measles and rubella -- Meningococcal disease -- Legionnaires' disease -- Vectorborne diseases -- Ciguatera -- References -- Chapter 5 Microbes on the move: prevention, required vaccinations, curtailment, outbreak.

Prevention of disease in travellers -- Protection of travelers and destination populations -- Yellow fever -- Imported disease -- Curtailment of disease -- New times, new requirements -- Expanded scope -- Decision instrument and notification -- Focal and contact points -- National core surveillance and response capacities -- Response to outbreaks -- Conclusion -- References -- Chapter 6 Diagnostic tests and procedures -- Understanding diagnostic tests -- Is a result positive or not? -- Validation of diagnostic tests -- CNS infections: meningitis, encephalitis -- Biochemistry/cytology -- Microbiology -- Imaging -- Ear, nose, and throat -- Biochemistry/cytology -- Rapid tests -- Microbiology -- Imaging -- Pulmonary infections -- Biochemistry/cytology -- Microbiology and rapid tests -- Imaging -- Cardiac infections -- Microbiology -- Imaging -- Gastrointestinal infections -- Biochemistry/cytology -- Microbiology -- Imaging -- Hepatobiliary infections -- Biochemistry/cytology -- Microbiology -- Imaging -- Upper and lower urinary tract infections -- Biochemistry/cytology -- Microbiology and rapid tests -- Imaging -- Sexually transmitted diseases and other genital infections -- Biochemistry -- Microbiology and rapid tests -- Joint, muscle, skin, and soft tissue infections -- Biochemistry/cytology -- Microbiology -- Imaging -- Rash -- Biochemistry -- Microbiology -- Imaging -- Fever without focal symptoms -- Initial tests on admission -- Biochemistry/cytology -- Microbiology -- Imaging -- Other -- Continued testing -- Zika virus infection -- Detection of Zika virus RNA -- Zika IgM-ELISA -- Malaria -- Eosinophilia and elevated IgE -- Biochemistry -- Microbiology -- Imaging -- Diagnostics in areas with limited resources -- Basic diagnostics of pulmonary infections -- Basic diagnostics of gastrointestinal symptoms.

Basic diagnostics of sexually transmitted infections -- Basic diagnostics of patients with adenopathy -- References -- Chapter 7 Central Africa -- Dominating the picture: HIV and tuberculosis -- CNS infections: meningitis, encephalitis -- Acute CNS infections with less than four weeks of symptoms -- Chronic CNS infections with more than four weeks of symptoms in immunocompetent and immunocompromised patients -- Ear, nose, throat, and upper respiratory tract infections -- Acute and chronic infections -- Ear, nose, and throat infections in immunocompromised host -- Cardiopulmonary infections -- Acute infections with less than four weeks of symptoms -- Chronic infections with more than four weeks of symptoms -- Infections in the immunocompromised host -- Gastrointestinal infections -- Gastrointestinal infections with less than four weeks of symptoms -- Chronic gastrointestinal infections with more than four weeks of symptoms -- Diarrhea in the immunocompromised host -- Infections of liver, spleen, peritoneum -- Acute infections of liver, spleen, peritoneum with less than four weeks of symptoms -- Chronic infections of liver, spleen, peritoneum with more than four weeks of symptoms -- Infections of liver, spleen, peritoneum in immunocompromised host -- Genitourinary infections -- Acute genitourinary infections with less than four weeks of symptoms -- Chronic genitourinary infections with more than four weeks of symptoms -- Cystitis, pyelonephritis, and nephritis infections in the immunocompromised host -- Sexually transmitted diseases in the immunocompromised host -- Infections of joints, muscle, and soft tissue -- Acute infections of bone, joints, and muscle with less than four weeks of symptoms -- Chronic infections of bone, joints, and muscle with more than four weeks of symptoms and in the immunocompromised host -- Infections of skin and soft tissues.

Skin infections -- Soft tissue infections -- Skin infections in immunocompromised host -- Lymphadenopathy -- Acute lymphadenopathy with less than four weeks of symptoms -- Chronic lymphadenopathy -- Fever without focal symptoms -- Acute fever with less than four weeks of symptoms -- Chronic fever with more than four weeks of symptoms in immunocompetent and immunocompromised patients -- Eosinophilia -- Children -- Antibiotic resistance -- Demographic data -- Basic economic and demographic data -- Distribution of causes of death in 0-4 year olds, 2013 (in %) in selected countries -- References -- Chapter 8 East Africa: Madagascar and Indian Ocean Islands -- CNS infections: meningitis, encephalitis -- Acute infections with less than four weeks of symptoms -- Infection with symptoms for more than four weeks and in the immunocompromised host -- Ear, nose, and throat infections -- Ear, nose, and throat infections with less than four weeks symptoms -- Ear, nose, and throat with symptoms for more than four weeks and in the immunocompromised host -- Cardiopulmonary infections -- Pneumonia with less than four weeks symptoms -- Endocarditis with less than four weeks symptoms -- Pulmonary symptoms for more than four weeks and in the immunocompromised host -- Endocarditis for more than four weeks and in the immunocompromised host -- Gastrointestinal infections -- Gastrointestinal infections with less than four weeks symptoms -- Gastrointestinal infections with symptoms for more than four weeks and in the immunocompromised host -- Infections of liver, spleen, peritoneum -- Acute infections of liver, spleen, peritoneum with less than four weeks of symptoms -- Chronic infections of liver, spleen, peritoneum with more than four weeks of symptoms -- Infections of liver, spleen, peritoneum in immunocompromised host -- Genitourinary infections.

Cystitis, pyelonephritis, and nephritis with less than four weeks symptom -- Sexually transmitted infections with less than four weeks symptoms -- Cystitis, pyelonephritis, and nephritis with symptoms for more than four weeks and in the immunocompromised host -- Sexually transmitted infections with symptoms for more than four weeks and in the immunocompromised host -- Joint, muscle, and soft tissue infections -- Joint, muscle, and soft tissue infections with less than four weeks symptoms -- Joint, muscle, and soft tissue infections with more than four weeks symptoms and in the immunocompromised host -- Skin infections -- Skin infections with less than four weeks symptoms -- Skin infections with more than four weeks symptoms and in the immunocompromised host -- Adenopathy -- Adenopathy of less than 4 weeks duration -- Adenopathy of more than four weeks duration and in the immunocompromised host -- Fever without focal symptoms -- Fever for less than four weeks without focal symptoms -- Fever for more than four weeks without focal symptoms and in the immunocompromised host -- Eosinophilia and elevated IgE -- Eosinophilia and elevated IgE for less than four weeks -- Eosinophilia and elevated IgE for more than four weeks and in the immunocompromised host -- Antibiotic resistance -- Vaccine-preventable diseases in children -- Basic economic and demographic data -- References -- Chapter 9 Eastern Africa -- Parasites -- Malaria transmission in Eastern Africa -- Virus -- Bacteria -- CNS infections: meningitis, encephalitis, and other infections with neurological symptoms -- Acute CNS infections with less than four weeks of symptoms -- CNS infections with more than four weeks symptoms and in the immunocompromised host -- Ear, nose, and throat infections -- Ear, nose, and throat infections with less than four weeks symptoms.

Ear, nose, and throat infections with more than four weeks symptoms and in the immunocompromised host.

Description based on publisher supplied metadata and other sources.

Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.